Neurotoxic effects induced by the Drosophila amyloid-beta peptide suggest a conserved toxic function

Katia Carmine-Simmen1, Thomas Proctor, Jakob Tschäpe

  • 1Center for Research on Occupational and Environmental Toxicology, Oregon Health and Science University, Portland, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.

Neurobiology of Disease
|December 4, 2008
PubMed

Insights

Alzheimer's disease (AD) amyloid-beta (Abeta) neurotoxicity is conserved across species. Fruit fly Abeta fragments form fibrils and cause neurodegeneration, suggesting conserved pathogenesis mechanisms in APP proteins.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Amyloid-beta (Abeta) plaque accumulation is a hallmark of Alzheimer's disease (AD).
  • Previous research suggested Abeta neurotoxicity was specific to human amyloid precursor protein (APP).

Purpose of the Study:

  • To investigate if Abeta fragments from non-human organisms can induce neurotoxicity and amyloid deposits.
  • To explore the conserved mechanisms of APP protein function and neurodegeneration.

Main Methods:

  • Generated and analyzed Abeta fragments from the Drosophila orthologue of APP (APPL).
  • Assessed fibril formation, amyloid deposit induction, and neurodegenerative effects in Drosophila.
  • Identified a novel fly beta-secretase-like enzyme involved in APPL cleavage.

Main Results:

  • Drosophila APPL-derived Abeta fragments aggregate into intracellular fibrils and amyloid deposits.
  • These fragments cause age-dependent behavioral deficits and neurodegeneration in flies.
  • Behavioral changes preceded extracellular amyloid deposit formation, highlighting intracellular Abeta's role.

Conclusions:

  • Abeta-induced neurotoxicity is a conserved function of APP proteins, not limited to humans.
  • Secondary structural aspects, rather than primary sequence, may determine Abeta pathogenesis.
  • Intracellular Abeta plays a critical role in AD pathogenesis, preceding extracellular plaque formation.